Chemical Structure (Ipratropium 01)
Ipratropium Bromide
Product Images NDC 0781-7157
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 0781-7157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Ipratropium 02)
Figure 2 (Ipratropium 03)
Figure 3 (Ipratropium 04)
Principal Display Panel (25 Ampule Carton)
Ipratropium Bromide Inhalation Solution is presented in a 0.02% solution with a 0.5mg strength, intended for oral inhalation only in 25 x 25mL unit-dose vials. Each vial contains a solution made up of Ipratropium Bromide 0.02%, preservative-free, and a sterile aqueous solution containing Sodium Chloride, adjusted to a pH of 3.4 with Hydrochloric Acid. Dosage instructions are not provided with the solution. The product should be stored at room temperature between 15°C and 30°C and protected from light.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
